FOXO4-DRI Pen

FOXO4-DRI is a modified peptide designed for research into cellular signalling mechanisms, particularly those involving transcription factors and regulatory protein interactions. In research settings, it is used to study FOXO4-related pathways and controlled experimental systems.

This reference is identified by its documented formulation and analytical batch record. Confirm structural identity and presentation details with the NORVEXA Bioscience documentation team.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

FOXO4-DRI 10 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.